[1]
Kumar, V. and Panda, B.K. 2017. CAN COST OF PHARMACOLOGICAL THROMBOLYTIC THERAPY BE A MEDICATION MANAGEMENT STRATEGY FOR ACUTE CORONARY SYNDROME?. Asian Journal of Pharmaceutical and Clinical Research. 10, 3 (Mar. 2017), 363-366. DOI:https://doi.org/10.22159/ajpcr.2017.v10i3.16308.